Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide.
$109.43+2.09%
报价 2026-11-13
市值
$36.39B
EV
$40.21B
PE (TTM)
11.0x
预期 PE (FY2026)
15.0x
52 周区间距高点 -4.6%
$93.05$114.74
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
爆发潜力
2026-11-13未命中≈ 收入线✗ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22027-12 | 2.0x | 7.33 → 7.32（1.0x） | 15.0 |
| FY+32028-12 | 1.7x | 7.33 → 8.03（1.1x） | 13.6 |
毛利率 36% · TTM 收入 $16566M · 基数 EPS 7.33（调整后）
电话会信号
辅助标签Q3 20262026-11-05
融资需求
指引 维持
信心 4
分析师 3
“We are confident in our ability to drive sustainable growth in 2027 and beyond.”
原文引用（1）
- 融资需求：adjusted EPS dilution not expected to be more than mid-single digit dilutive, versus standalone KC
蓝色标签在暴涨研究中略有区分度；悬停查看口径。
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| KMBKimberly-Clark Corporation | $36.39B | +2.1% | +9.6% | 34.9% | 11.0x | 13.1x | 18.6x | |
| KDPKeurig Dr Pepper Inc. | $49.46B | +2.6% | +59.5% | 48% | 17.3x | 12.7x | – | 高增长 |
| ABEVAmbev S.A. | $43.22B | +1.1% | – | 51% | 14.8x | 7.6x | – | |
| ELThe Estée Lauder Companies Inc. | $40.49B | +1.1% | +6.2% | 75.5% | 213.4x | 27.4x | 30.0x | |
| SYYSysco Corporation | $37.95B | +1.1% | +5.9% | 18.5% | 21.8x | 13.3x | 17.3x | |
| HSYThe Hershey Company | $35.02B | +0.6% | +6.1% | 46.1% | 49.6x | 27.4x | 14.9x | |
| ADMArcher-Daniels-Midland Company | $34.69B | +2.7% | +6.3% | 5.8% | 30.5x | 10.4x | 100.3x | |
| JBSJBS N.V. | $26.97B | +2.2% | +0.5% | 10.8% | 13.4x | 7.5x | 67.9x | |
| CHDChurch & Dwight Co., Inc. | $26.67B | +1.4% | +0.8% | 44.7% | 30.7x | 18.9x | 25.2x | |
| 同行中位数 | – | – | +6.1% | 45.4% | 26.1x | 13.0x | 27.6x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-09-30 Q3 2026 | 2026-06-30 Q2 2026 | 2026-03-31 Q1 2026 | 2025-12-31 Q4 2025 | 2025-09-30 Q3 2025 | 2025-06-30 Q2 2025 | 2025-03-31 Q1 2025 | 2024-12-31 Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.13B | $4.19B | $4.16B | $4.08B | $4.13B | $4.16B | $4.84B | $4.93B |
| Gross Margin | 34.9% | 38.3% | 36.8% | 35.9% | 35.7% | 35% | 35.8% | 34% |
| Operating Margin | 12.5% | 10.7% | 11.4% | 12.4% | 15% | 14.2% | 15.9% | 11.1% |
| Net Income | $1.79B | $345M | $665M | $499M | $446M | $509M | $567M | $447M |
| Diluted EPS | 5.37 | 1.04 | 2 | 1.5 | 1.34 | 1.53 | 1.7 | 1.34 |
| Operating Cash Flow | $755M | $908M | $745M | $972M | $708M | $770M | $327M | $817M |